The molecular basis of Conantokin antagonism of NMDA receptor function

Current Drug Targets

Volumn 8, Issue 5, 2007, Pages 633-642

  Prorok, Mary ^a   Castellino, Francis J ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

Conantokin inhibition; Ionotropic glutamate receptors; Long term potentiation; NMDAR antagonists; NR1 exons

Indexed keywords

2 AMINO 7 PHOSPHONOHEPTANOIC ACID; 4 PHOSPHONOMETHYLPIPECOLIC ACID; 6,7 DICHLORO 5 NITRO 2,3 QUINOXALINEDIONE; 6,7 DINITRO 2,3 QUINOXALINEDIONE; AMINO ACID; AMPA RECEPTOR; CONANTOKIN DERIVATIVE; CONANTOKIN G; CONANTOKIN L; CONANTOKIN R; CONANTOKIN T; DIZOCILPINE; ELIPRODIL; GAVESTINEL; GLUTAMATE RECEPTOR AGONIST; GLUTAMATE RECEPTOR ANTAGONIST; IFENPRODIL; IONOTROPIC RECEPTOR; IONOTROPIC RECEPTOR ANTAGONIST; KAINIC ACID RECEPTOR; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROPROTECTIVE AGENT; PHENCYCLIDINE; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACUTE DISEASE; AMINO ACID SEQUENCE; ANTICONVULSANT ACTIVITY; ANTINOCICEPTION; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; CHRONIC PAIN; DEGENERATIVE DISEASE; DELIRIUM; DRUG BINDING SITE; DRUG DESIGN; DRUG EFFICACY; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; DRUG SAFETY; ENZYME INHIBITION; HALLUCINATION; HUMAN; INFLAMMATORY DISEASE; MOLECULAR MECHANICS; NEUROLOGIC DISEASE; NEUROPATHIC PAIN; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SEIZURE; STRUCTURE ACTIVITY RELATION;

ANIMALS; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; MOLLUSK VENOMS; PEPTIDES, CYCLIC; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 34249010244     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/138945007780618481     Document Type: Review

References (110)

1. Simon, R.P.; Swan, J.H.; Griffiths, T. and Meldrum, B.S. (1984) Science, 226(4676), 850-852.
2. Jentsch, J.D. and Roth, R.H. (1999) Neuropsychopharmacology, 20(3),201-225.
3. Olney, J.W.; Newcomer, J.W. and Farber, N.B. (1999) J. Psychiatr. Res., 33(6), 523-533.
4. Davis, S.M.; Lees, K.R.; Albers, G.W.; Diener, H.C.; Markabi, S.; Karlsson, G. and Norris, J. (2000) Stroke, 31(2), 347-354.
5. Lees, K.R.; Asplund, K.; Carolei, A.; Davis, S.M.; Diener, H.C.; Kaste, M.; Orgogozo, J.M. and Whitehead, J. (2000) Lancet, 355(9219), 1949-1954.
6. Albers, G.W.; Clark, W.M.; Atkinson, R.P.; Madden, K.; Data, L. and Whitehouse, M.J. (1999) Stroke, 30(3), 508-513.
7. Ikonomidou, C. and Turski, L. (2002) Lancet Neurol., 1(6), 383-386.
8. Hallett, P.J and Standaert, D.G. (2004) Pharmacol. Ther., 102(2), 297-304.
9. Meldrum, B. S. (1994) Neurology, 44(11), S14-S23.
10. Woolf, C.J. and Thompson, S.W. (1991) Pain, 44(3), 293-199.
11. Ulas, J.; Weihmeller, F.B.; Brunner, L.C.; Joyce, J.N.; Marshall, J.F. and Cotman, C.W. (1994) J. Neurosci., 14(11), 6317-6324.
12. Bisaga, A. and Popik, P. (2000) Drug Alcohol Depend., 59(1), 1-15.
13. Paul, I.A. and Skolnick, P. (2003) Ann. N.Y. Acad. Sci, 1003, 250-272.
14. Wei, F.; Wang, G.D.; Kerchner, G.A.; Kim, S.J.; Xu, H.M.: Chen, Z.F. and Zhuo, M. (2001) Nat. Neurosci., 4(2), 164-169.
15. Nash, J.E.; Hill, M.P. and Brotchie, J.M. (1999) Exp. Neurol., 155, 42-48.
16. Narita, M.; Soma, M.; Mizoguchi, H.; Tseng, L.F. and Suzuki, T. (2000) Eur. J. Pharmacol., 401(2) 191-195.
17. Terlau, H. and Olivera, B.M. (2004) Physiol. Rev., 84(1), 41-68.
18. McIntosh, J.; Olivera, B.M.; Cruz, L. and Gray, W. (1984) J. Biol. Chem., 259(23), 14343-14346.
19. Haack, J.A.; Rivier, J,; Parks, T.N.; Mena, E.E.; Cruz, L.J. and Olivera, B.M. (1990) J. Biol. Chem., 265(11), 6025-6029.
20. White, H.S.; McCabe, R.T.; Armstrong, H.; Donevan, S.D.; Cruz, L.J.; Abogadie, F.C.; Torres, J.; Rivier, J.E.; Paarmann, I.; Hollmann, M. and Olivera, B.M. (2000) J. Pharmacol. Exp. Ther. 292(1), 425-432.
21. Jimenez, E.C.; Donevan, S.; Walker, C.; Zhou, L.M.; Nielsen, J.; Cruz, L.J.; Armstrong, H.; White, H.S. and Olivera, B.M. (2002) Epilepsy Res., 51(1-2), 73-80.
22. Malmberg, A.B.; Gilbert, H.; McCabe, R.T. and Basbaum, A.L. (2003) Pain, 101(1-2), 109-116.
23. Barton, M.E.; White, H.S. and Wilcox, K.S. (2004) Epilepsy Res., 59(1), 13-24.
24. Barton, M.E. and White, H.S. (2004) Epilepsy Res., 59(1), 1-12.
25. Williams, A.J.; Ling, G.; McCabe, R.T. and Tortella, F.C. (2002) Neuroreport, 13(6), 821-824.
26. MacDermott, A.B.; Mayer, M.L.; Westbrook, G.L.; Smith, S.J. and Barker, J.L. (1986) Nature, 321(6069), 519-522
27. Johnson, J.W. and Ascher, P. (1987) Nature, 325 (6104), 529-531.
28. Mothet, J.P.; Parent; A.T.; Wolosker, H.; Brady, R.O. Jr.; Linden, D.J.; Ferris, C.D.; Rogawski M.A. and Snyder, S.H. (2000) Proc. Natl. Acad. Sci. USA, 97(9), 4926-4931
29. Mayer, M.L.; Westbrook, G.L. and Guthrie, P.B. (1984) Nature, 309(5965), 261-263.
30. Rock D.M, and MacDonald, R.L. (1992) Mol. Pharmacol., 42(1), 157-164.
31. Pritchard, G.A.; Fahey, J.M.; Minocha, S.C.; Conaty, C. and Miller, L.G. (1994) Eur. J. Pharmacol., 266(2), 107-115.
32. Christine, C.W. and Choi, D.W. (1990) J. Neurosci., 10(1), 108-116.
33. Traynelis, S.F. and Cull-Candy, S.G. (1990) Nature, 345(6273), 347-350.
34. Choi, Y.B. and Lipton, S.A. (2000) Cell Mol. Life Sci., 57(11), 1535-1541
35. Swope, S.L.; Moss, S.J.; Raymond, L.A. and Huganir, R.L. (1999) Adv. Second Messenger Phosphoprotein Res., 33, 49-78
36. Moriyoshi, K.; Masu, M.; Ishii, T.; Shigemoto, R.; Mizuno, N. and Nakanishi, S. (1991) Nature, 354 (6348), 31-37.
37. Hollmann, M. and Heinemann, S. (1994) Annu. Rev. Neurosci., 17, 31-108.
38. Ciabarra, A.M.; Sullivan, J.M.; Gahn, L.G.; Pecht, G.; Heinemann, S. and Sevarino, K.A. (1995) J. Neurosci., 15(10), 6498-6508.
39. Chatterton, J.E.; Awobuloy, M.; Premkumar, L.S.; Takahashi, H.; Talantova, M.; Shin, Y.; Cui, J.: Tu, S.; Sevarino, K.A.; Nakanishi, N.; Tong, G.; Lipton, S.A. and Zhang, D. (2002) Nature, 415(6873), 793-798.
40. Sugihara, H.; Moriyoshi, K.; Ishii, T.; Masu, M. and Nakanishi, S. (1992) Biochem. Biophys. Res. Commun., 185(3), 826-832.
41. Hollmann, M.; Boulter, J.; Maron, C.; Beasley, L.; Sullivan, J.; Pecht, G. and Heinemann, S. (1993) Neuron, 10(5), 943-954.
42. Wo, Z.G. and Oswald, R.E. (1994) Proc. Natl. Acad. Sci. USA, 91(15), 7154-7158.
43. Kuner, T.; Seeburg, P.H. and Guy, H.R. (2003) Trends Neurosci., 26(1), 27-32.
44. Wood, M.W.; VanDongen, H.M. and VanDongen, A.M. (1997) J. Biol. Chem., 272(6), 3532-3537.
45. Kawajiri, S. and Dingledine, R. (1993) Neuropharmacology, 32(11), 1203-1211.
46. Sakurada, K.; Masu, M. and Nakanishi, S. (1993) J. Biol. Chem., 269(1), 410-415.
47. Tingley, W.G.; Roche, K.W.; Thompson, A.K. and Huganir, R.L. (1993) Nature, 364(6432), 70-73.
48. Suchanek, B.; Seeburg, P.H. and Sprengel, R. (1995). J. Biol. Chem., 270(1), 41-44.
49. Monyer, H.; Sprengel, R.; Schoepfer, R.; Herb, A.; Higuchi, M.; Lomeli, H.; Burnashev, N.; Sakmann, B. and Seeburg, P.H. (1992) Science, 256(5060), 1217-1221.
50. Ikeda, K.; Nagasawa, M.; Mori, H.; Araki, K.; Sakimura, K.; Watanabe, M.; Inoue, Y. and Mishina, M. (1992) FEBS Lett., 313(1), 34-38.
51. Papadakis, M.; Hawkins, L.M. and Stephenson, F.A. (2004) J. Biol. Chem., 279(15), 14703-14712.
52. Behe, P.; Stern, P.; Wyllie, D.J.; Nassar, M.; Schoepfer, R. and Colquhoun, D. (1995) Proc. Biol. Soc., 262(1364), 205-213.
53. Hawkins, L.M.; Chazot, P.L. and Stephenson, F.A. (1999) J. Biol. Chem., 274(38), 27211-27218.
54. Laube, B.; Kuhse, J. and Betz, H. (1998) J. Neurosci., 18(8), 2954-2961.
55. Premkumar, L.S. and Auerbach, A. (1997) J. Gen. Physiol., 110(5), 485-502.
56. Luo, J.; Wang, Y.; Yasuda, R.P.; Dunah, A.W. and Wolfe B.B. (1997) Mol. Pharmacol., 51(1), 79-86.
57. Stern-Bach, Y.; Bettler, B.; Hartley, M.; Sheppard, P.O.; O'Hara, P.J. and Heinemann, S.F. (1994) Neuron, 13(6), 1345-1357.
58. Swanson, G.T.; Gereau, R.W.; Green, T. and Heinemann, S.F. (1997) Neuron, 19(4), 913-926.
59. Paas, Y.; Eisenstein, M.; Medevielle, F.; Teichberg, V.I. and Devellers-Thiery, A. (1996) Neuron, 17(5), 979-990.
60. Armstrong, N. and Gouaux, E. (2000) Neuron, 28(1), 165-181.
61. Furukawa, H. and Gouaux, E. (2003) EMBO J. 22(12), 2873-2885.
62. Meddows, E.; Le Bourdelles, B.; Grimwood, S.; Wafford, K.; Sandhu, S.; Whiting, P. and McIlhinney, R.A. (2001) J. Biol. Chem., 276(22), 18795-18803.
63. Ivanovic, A.; Reilander, H.; Laube, B. and Kuhse, J. (1998) J. Biol. Chem., 273(32), 19933-19937.
64. Laube, B.; Schemm, R. and Betz, H. (2004) Neuropharmacology, 47(7), 994-1007.
65. Chen, P.E.; Geballe, M.T.; Stansfeld, P.J.; Johnston, A.R.; Yuan, H.; Jacob, A.L.; Snyder, J.P.; Traynelis, S.F. and Wyllie, D.J. (2005) Mol. Pharmacol., 67(5), 1470-1484.
66. Watanabe, M.; Inoue, Y.; Sakimura, K. and Mishina, M. (1992) Neuroreport, 3(12), 1138-1140.
67. Stocca, G. and Vicini, S. (1998) J. Physiol. (Lond.), 507(1), 13-24.
68. Tovar, K.R. and Westbrook, G.L. (1999) J. Neurosci., 19(10), 4180-4188.
69. Massey, P.V.; Johnson, B.E.; Moult, P.R.; Auberson, Y.P.; Brown, M.W.; Molnar, E.; Collingridge, G.L. and Bashir, Z.I. (2004) J. Neurosci., 24(36), 7821-7828.
70. Wafford, K.A.; Bain, C.J.; Le Bourdelles, B.; Whiting, P.J. and Kemp, J.A. (1993) Neuroreport, 4(12), 1347-1349.
71. Laube, B.; Hirai, H.; Sturgess, M.; Betz, H. and Kuhse, J. (1997) Neuron, 18(3), 493-503.
72. Linden, A.M.; Vasainen, J.; Wong, G. and Castren, E. (1997) Eur. J. Pharmacol., 319(1), R1-R2.
73. Krupp, J.J.; Vissel, B.; Heinemann, S.F. and Westbrook, G.L. (1996) Mol. Pharmacol., 50(6), 1680-1688.
74. Jones, M.L. and Leonard, J.P. (2005) J. Neurochem., 92(6), 1431-1438.
75. Corsi, L.; Li, J.H.; Krueger, K.E.; Wang, Y.H.; Wolfe, B.B. and Vicini, S. (1998) J. Neurochem., 70(5), 1898-1906.
76. Sala, C.; Rudolph-Correia, S. and Sheng, M. (2000) J. Neurosci., 20(10), 3529-3536.
77. Bliss, T.V. and Collingridge, G.L. (1993) Nature, 361(6407), 31-39.
78. Rickard, N.S.; Poot, A.C.; Gibbs, M.E. and Ng, K.T. (1994) Behav. Neural Biol., 62(1), 33-40.
79. Tang Y.-P.; Shimizu, E.; Dube, G.R.; Rampon, C.; Kerchner, G.A.; Zhuo, M.; Liu, G. and Tsien, J.Z. (1999) Nature, 401(6748), 63-69.
80. Tang, Y.P.; Wang, H.; Feng, R.; Kyin, M. and Tsien, J.Z. (2001) Neuropharmacology, 41(6), 779-790.
81. Mattson, M.P.; Rydel, R.E.; Lieberburg, I. and Smith-Swintosky, V.L. (1993) Ann. N.Y. Acad. Sci., 679, 1-21.
82. Waxman, E.A. and Lynch, D.R. (2005) Neuroscientist, 11(1), 37-49.
83. Chazot, P.L. (2004) Curr. Med. Chem., 11(3), 389-396.
84. Castellino, F.J. and Prorok, M. (2000), Curr. Drug Targets, 1(3), 219-235.
85. Prorok, M. and Castellino, F.J. (2001), Curr. Drug Targets, 2(3), 313-322.
86. Dai, Q.; Prorok, M. and Castellino, F.J. (2004) J. Mol. Biol., 336(3), 731-744.
87. Blandl, T., Prorok, M. and Castellino, F.J. (1998) FEBS Lett., 435(2-3), 257-262.
88. Warder, S.E.; Blandl, T.; Klein, R.C.; Castellino, F.J., and Prorok, M. (2001) J. Neurochem., 77(3), 812-822.
89. Mena, E.E.; Gullak, M.F.; Pagnozzi, M.J.; Richter, K.E.; Rivier, J.; Cruz, L.J. and Olivera B.M. (1990) Neurosci. Lett., 118(2), 241-244.
90. Skolnick, P.; Boje, K.; Miller, R.; Pennington, M. and Maccecchini, M.-L. (1992) J. Neurochem., 59(4), 1516-1521.
91. Haack, J.A; Parks, T.N. and Olivera, B.M. (1993) Neurosci. Lett., 163(1), 63-66.
92. Hammerland, L.G.; Olivera, B.M., and Yoshikami, D. (1992) Eur. J. Pharmacol., 226(3), 239-244.
93. Klein, R.C.; Galdzicki, Z. and Castellino, F.J. (1999) Neuropharmacology, 38(12), 1819-1829.
94. Klein, R.C.; Warder, S.E.; Galdzicki, Z.; Castellino, F.J. and Prorok, M. (2001), Neuropharmacology, 41(7), 801-810.
95. Donevan, S.D. and McCabe, R.T. (2000) Mol. Pharmacol., 58(3), 614-623.
96. Wittekindt, B.; Malany, S.; Schemm, R.; Otvos, L.; Maccecchini, M.-L.; Laube, B. and Betz, H. (2001) Neuropharmacology, 41(6), 733-761.
97. Skjaerbaek, N.; Nielsen, K.J.; Lewis, R.J.; Alewood, P. and Craik, D.J. (1997) J. Biol. Chem., 272(4), 2291-2299.
98. Klein, R.C.; Prorok, M. and Castellino, F.J. (2003) J. Peptide Res., 61(6), 307-317.
99. Nelsestuen, G.L. and Lim, T.K. (1977) Biochemistry, 16(19), 4164-4171.
100. Zhang, L. and Castellino, F.J. (1993) J. Biol. Chem., 268(16), 12040-12045.
101. Lynch, D.R.; Lawrence, J.J.; Lenz, S.; Anegawa, N.J., Dichter, M. and Pritchett, D.B. (1995) J. Neurochem., 64(4), 1462-1468.
102. Gallagher, M.J.; Huang, H.; Pritchett, D.B. and Lynch, D.R. (1996) J. Biol. Chem., 271(16), 9603-9611.
103. Choi, Y.B. and Lipton, S.A. (1999) Neuron, 23(1), 171-180.
104. Klein R.C.; Prorok, M; Galdzicki, Z. and Castellino, F.J. (2001) J. Biol. Chem., 276(29), 26860-26867.
105. Layer, R.T.; Wagstaff, J.D. and White, H.S. (2004) Curr. Med. Chem., 11(23), 3073-3084.
106. Staats, P.S.; Yearwood, T.; Charapata, S.G.; Presley, R.W.; Wallace, M.S.; Byas-Smith, M.; Fisher, R;, Bryce, D.A.; Mangieri, E.A.; Luther, R.R.; Mayo, M.; McGuire, D. and Ellis, D. (2004) JAMA, 291(1), 63-70.
107. Tan, P.H.; Yang, L.C.; Kan, K.C. and Cheng, J.T. (2005) Gene Ther., 12(1), 59-66.
108. Williams, A.J.; Dave, J.R.; Phillips, J.B.; Lin, Y.; McCabe, R.T. and Tortella, F.C. (2000) J. Pharmacol. Exp. Ther., 294(1), 378-386.
109. Williams, A.J.; Dave, J.R.; Lu, X.M.; Ling, G. and Tortella, F.C. (2002) Eur. J. Pharmacol., 452(1), 135-136.
110. Williams, A.J.; Ling, G.; Berti, R.; Moffett, J.R.; Yao, C.; Lu, X.M.; Dave, J.R. and Tortella, F.C. (2003) Exp. Brain. Res., 153(1), 16-26.